Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
74.49
+1.23 (1.68%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,170 | 3,476 | 2,117 | 670 | 391 | 465 | |
| Market Cap Growth | 73.35% | 64.21% | 215.74% | 71.44% | -15.95% | -44.60% | |
| Enterprise Value | 2,836 | 3,156 | 1,873 | 455 | 185 | 283 | |
| Last Close Price | 74.49 | 81.88 | 55.37 | 20.25 | 14.66 | 22.50 | |
| Forward PE | - | 97.48 | - | - | - | - | |
| PS Ratio | 7.02 | 7.70 | 11.57 | 38.42 | 15.15 | 8.16 | |
| PB Ratio | 9.23 | 10.12 | 9.43 | 3.40 | 2.03 | 2.79 | |
| P/TBV Ratio | 9.43 | 10.34 | 9.79 | 3.47 | 2.03 | 2.79 | |
| P/FCF Ratio | - | - | - | - | - | 147.13 | |
| P/OCF Ratio | - | - | - | - | - | 124.13 | |
| EV/Sales Ratio | 6.28 | 6.99 | 10.24 | 26.10 | 7.15 | 4.96 | |
| EV/FCF Ratio | - | - | - | - | - | 89.41 | |
| Debt / Equity Ratio | 0.24 | 0.24 | 0.32 | 0.15 | 0.10 | 0.01 | |
| Debt / FCF Ratio | - | - | - | - | - | 0.38 | |
| Net Debt / Equity Ratio | -0.97 | -0.97 | -0.97 | -1.00 | -1.02 | -1.02 | |
| Net Debt / EBITDA Ratio | 4.83 | 4.83 | 1.83 | 1.39 | 3.16 | 14.40 | |
| Net Debt / FCF Ratio | 14.98 | 14.98 | 2.59 | 1.66 | 3.97 | -53.96 | |
| Asset Turnover | 0.96 | 0.96 | 0.57 | 0.07 | 0.13 | 0.33 | |
| Inventory Turnover | 27.18 | 27.18 | 23.12 | - | - | - | |
| Quick Ratio | 3.72 | 3.72 | 4.21 | 6.64 | 14.30 | 14.98 | |
| Current Ratio | 3.85 | 3.85 | 4.43 | 6.93 | 14.61 | 15.33 | |
| Return on Equity (ROE) | -23.39% | -23.39% | -54.83% | -69.71% | -34.53% | -8.31% | |
| Return on Assets (ROA) | -9.45% | -9.45% | -23.46% | -36.27% | -19.27% | -4.33% | |
| Return on Capital Employed (ROCE) | -16.60% | -16.60% | -40.70% | -62.60% | -29.50% | -7.30% | |
| Earnings Yield | -2.10% | -1.91% | -5.46% | -20.27% | -15.88% | -2.97% | |
| FCF Yield | -0.70% | -0.64% | -4.00% | -17.75% | -12.67% | 0.68% | |
| Buyback Yield / Dilution | -11.11% | -11.11% | -27.98% | -19.35% | -19.78% | -231.12% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.